- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02883231
Plasma Level of Mitochondrial DNA in Patients With ARDS and Its Clinical Significance
August 25, 2016 updated by: Chun Pan
To observe the changes of plasma mitochondrial DNA (mtDNA) levels in patients with ARDS, and to explore its clinical significance.
Study Overview
Status
Unknown
Intervention / Treatment
Detailed Description
60 patients who diagnosed as ARDS were included in this study.Then keep blood samples from these patients in the first day、the third day and the sveventh day,detect the mitochotndrial DNA level in plasma by real-time quantitative PCR.
Recored Severity of illness and survival status of every patient within 28 days.Objective to evaluate the correlation between the level of mitochondrial DNA in plasma and the prognosis of the patients.
Study Type
Observational
Enrollment (Anticipated)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lili Huang, Dr
- Phone Number: 13770840246
- Email: caowangyou007@126.com
Study Contact Backup
- Name: Haibo Qiu, Dr
- Phone Number: +862583262550
- Email: haiboq2000@gmail.com
Study Locations
-
-
Jiangsu
-
Nanjing, Jiangsu, China, 210009
- Recruiting
- Zhongda Hospital
-
Contact:
- Lili Huang, Dr
- Phone Number: 13770840246
- Email: caowangyou007@126.com
-
Principal Investigator:
- Lili Huang, Dr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Population admitted to ICU of Zhongda hospital ,diagnosed of ARDS。
Description
Inclusion Criteria:
- Patients admitted to ICU diagnosed of ARDS (Berlin criteria),
- Patients age between 18 years old and 80 years.
Exclusion Criteria:
- Pregnant women,
- Patients with malignant tumor,
- Immunosuppression or immunocompromised patients.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
mortality
Time Frame: 28-day
|
28-day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2016
Primary Completion (Anticipated)
March 1, 2017
Study Completion (Anticipated)
March 1, 2017
Study Registration Dates
First Submitted
August 25, 2016
First Submitted That Met QC Criteria
August 25, 2016
First Posted (Estimate)
August 30, 2016
Study Record Updates
Last Update Posted (Estimate)
August 30, 2016
Last Update Submitted That Met QC Criteria
August 25, 2016
Last Verified
August 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- ARDS mtDNA
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Evaluate the Correlation Between the Level of Mitochondrial DNA in Plasma and the Prognosis of the Patients With ARDS.
-
Jingyuan,XuUnknownEvaluate the Correlation Between the Level of ESM-1 and the Prognosis of the Patients With ARDSChina
-
CerbaXpertRecruitingEvaluate the Physiological Stability of NIS4 Biomarker Between the Fed and Fasting State in Patients With the Target Condition (NAFLD)France
-
Hadassah Medical OrganizationCompletedTo Evaluate Effectiveness of the Gait Trainer in Increasing the Functionality and Spatiotemporal Parameters of Gait of 4 Patients.Israel
-
Stefania CostiArcispedale Santa Maria Nuova-IRCCSCompletedComplex Patients: Patients With High Level of Complexity Regardless of the Pathology of Origin
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingTo Evaluate the Safety and Tolerability of Intravitreal Injection of LX109 in Patients With nAMD
-
InvestigatorUrologyIBSALInstituto de Investigación Biomédica de SalamancaUnknownEstablish the Efficacy Between the Four Schemes in Terms of the Aggressiveness of the Tumors According to the Gleason Classification | Establish the Efficacy Between the Four Schemes in Terms of Morbidity Associated With the Technique | Establish the Efficacy Between the Four Schemes... and other conditionsSpain
-
Chulalongkorn UniversityRecruitingThe Retention of Iodine in Saliva Over the Time | The Comparison of Iodine in Saliva Between Gargle and SwabThailand
-
Mayo ClinicCompletedEvaluate the Role of Real-time Imaging in Needle Placement | Evaluate the Workflow and Effectiveness of Realtime Imaging Versus Standard MR ImagingUnited States
-
Jinnah Sindh Medical UniversityAl Khidmat Hospital Nazimabad Karachi; Medics Laboratories (Pvt.) Ltd.CompletedThe Main Focus of This Study is to Evaluate the Safety of Zingiber Officinale L. Tablets as Hypolipidemic Agent in Hypertensive PatientsPakistan
-
Tomey CorporationCompletedEvaluate the Agreement and Precision of Device SS-1000 and the Predicate Device the Pentacam in a Reproducibility and Repeatability TrialJapan
Clinical Trials on taking peripheral blood
-
Southeast University, ChinaNot yet recruiting
-
Jingyuan,XuUnknown
-
Chinese University of Hong KongCompletedGastrointestinal Hemorrhage | Melena | Hematemesis | Platelet DysfunctionChina
-
Centre Hospitalier Universitaire de BesanconUnknownThoracic or Abdominal Aortic Aneurysm With no Indication for Surgical TreatmentFrance
-
National Heart Centre SingaporeSingapore General Hospital; Abbott; Beckman Coulter GmbHCompleted
-
Assiut UniversityUnknown
-
Western Galilee Hospital-NahariyaMigal, Galilee Technology CenterUnknownOxidative Stress | LaproscopyIsrael
-
CHU de ReimsCompletedDosage of Serum Tryptase Levels in a Population of Premature Newborns to Evaluate Mast Cell ActivityPremature NewbornsFrance
-
Southeast University, ChinaUnknownARDS | Intensive Care Medicine